Skip to main content
JNJ logo
JNJ
(NYSE)
Johnson & Johnson
$243.04-- (--)
Loading... - Market loading

Johnson & Johnson (JNJ) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Johnson & Johnson
JNJNYSEHealthcareDrug Manufacturers - General

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Stock Details

ExchangeNYSE (NYSE)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone732 524 0400
Address
One Johnson & Johnson Plaza New Brunswick, New Jersey 08933 United States

Corporate Identifiers

CIK0000200406
CUSIP478160104
ISINUS4781601046
EIN22-1024240
SIC2834

Leadership Team & Key Executives

Joaquin Duato
Chief Executive Officer and Chairman
Dr. John C. Reed M.D., Ph.D.
Executive Vice President of Innovative Medicine and Research & Development
Timothy Schmid
Executive Vice President and Worldwide Chairman of MedTech
Robert J. Decker Jr.
Controller and Chief Accounting Officer
Darren Snellgrove
Vice President of Investor Relations
Dirk Brinckman
Chief Compliance Officer
Kristen Blair Mulholland
Executive Vice President and Chief Human Resources Officer
Dr. Guy J. Lebeau M.D.
Group Chairman of MD&D Business - EMEA
Vanessa Broadhurst
Executive Vice President of Global Corporate Affairs
Jessica Moore
Group Chief Financial Officer of Johnson and Johnson Innovative Medicine